Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Association of Gene Polymorphisms in Cyclophosphamide Metabolism Pathway with Complications after Haploidentical Hematopoietic Stem Cell Transplantation

Paula Muñiz Sevilla, Cristina Andres, Diego Carbonell, Mr, María Chicano Lavilla, PhD, Rebeca Bailen, Gillen Oarbeascoa, Julia Suárez González, Javier Anguita, MD PhD, Mi Kwon, Jose L. Diez-Martin, MD PhD, Carolina Martínez-Laperche, PhD, Ismael Buño

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-136049

Published: 2020

Journal Articles

Impact of Minimal Residual Disease and Chimerism Monitoring at Different Timepoints after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Reyes María Martín-Rojas, MD, Gillen Oarbeascoa, MD, Rebeca Bailén, MD, Ignacio Gómez-Centurión, MD, Luis Miguel Juarez, MD, Nieves Dorado, MD, Carolina Martínez-Laperche, PhD, Ana Pérez-Corral, MD PhD, Ismael Buño, PhD, Javier Anguita, MD PhD, Jose L. Diez-Martin, MD PhD, Mi Kwon, MDPhD

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-141064

Published: 2020

Journal Articles

ST2 As a Biomarker of Non-Relapse Mortality after HLA-Haploidentical SCT with High-Dose Post-Transplantation Cyclophosphamide

Laura Solán, PhD, Carolina Martínez-Laperche, PhD, Mi Kwon, Diego Carbonell, Pascual Balsalobre, David Serrano, María Chicano, PhD, Julia Suárez-González, Javier Anguita, MD PhD, Jorge Gayoso, MD, Ismael Buño, Jose L. Diez-Martin, MD PhD

Blood (2017) 130 (Supplement 1): 3313.

https://doi.org/10.1182/blood.V130.Suppl_1.3313.3313

Published: 2017

Journal Articles

Immune Reconstitution Impact on Overall Survival after Hematopoietic Haploidentical Stem Cell Transplantation

Ana Perez-Corral, MD PhD, Nieves Dorado, MD, Virginia Pradillo, MD, Jorge Gayoso, MD, Javier Anguita, MD PhD, Mi Kwon, MD, Crsitina Pascual, MD PhD, David Serrano, MD, Juan Churruca, MD, Pascual Balsalobre, Carolina Martinez-Laperche, PhD, Jose Luis Diez-Martin, MD PhD

Blood (2016) 128 (22): 5779.

https://doi.org/10.1182/blood.V128.22.5779.5779

Published: 2016

Journal Articles

Influence of CD34+ and CD3+ Graft Content on Gvhd Development after Haploidentical Allogeneic Transplantation with Post-Transplant Cyclophosphamide

Mariana Bastos-Oreiro, MD, Pascual Balsalobre, PhD, Diana Champ, MD, Juan Churruca, MD, Maria Jesus Pascual, MD, Pilar Herrera, MD, Leyre Bento, MD, Jose Luis Piñana, MD, Santiago Jimenez, MD, Karem Humala, MD, Pau Montesinos, MD, Inmaculada Heras, MD, Almudena Iglesias, MD, Ana Perez-Corral, MD, Cristina Pascual, MD, Carolina Martinez-Laperche, PhD, Mi Kwon, MD, Jorge Gayoso, MD, Jose L. Diez-Martin, MD PhD

Blood (2015) 126 (23): 3131.

https://doi.org/10.1182/blood.V126.23.3131.3131

Published: 2015

Journal Articles

A Novel Quantitative PCR Approach Targeting Insertion/Deletion Polymorphisms (Indel-PCR) for Chimerism Quantification: Finally High Sensitivity and Quantification Capacity Together

Almudena Navarro-Bailón, MD, Carolina Martinez-Laperche, PhD, Diego Carbonell, Elena Buces, Milagros González-Rivera, Mariana Bastos, Pascual Balsalobre, Mi Kwon, MD, David Serrano, Javier Anguita, MD PhD, Jorge Gayoso, MD, Jose Luis Diez-Martin, MD PhD, Ismael Buño, PhD

Blood (2015) 126 (23): 4277.

https://doi.org/10.1182/blood.V126.23.4277.4277

Published: 2015

Journal Articles

Donor and Recipient Genotypes for Interleukin 1 Gene Single Nucleotide Polymorphisms (SNPs) Allow Anticipation of Acute Graft Versus Host Disease after HLA-Identical Allogeneic Stem Cell Transplantation (allo-SCT)

Blood (2014) 124 (21): 666.

https://doi.org/10.1182/blood.V124.21.666.666

Published: 2014

Journal Articles

Calreticulin Mutations in JAK2-Negative Myeloproliferative Neoplasms. Experience in Our Center

Maria Jose Penalva Moreno, Carolina Martinez-Laperche, PhD, Santiago Osorio Prendes, Elena Buces Gonzalez, Jose Luis Diez-Martin, MD PhD, Ismael Buño Borde

Blood (2014) 124 (21): 5586.

https://doi.org/10.1182/blood.V124.21.5586.5586

Published: 2014

Journal Articles

Chromosome 8 Abnormalities (8p Losses and 8q Gains) in Patients with Chronic Lymphocytic Leukemia (CLL) and Del(17p)

Blood (2014) 124 (21): 5638.

https://doi.org/10.1182/blood.V124.21.5638.5638

Published: 2014

Journal Articles

Myelodysplastic Syndromes with I(17)(q10) and Prognostic Implications of Mutations of TP53 and SETBP1

Blood (2014) 124 (21): 1910.

https://doi.org/10.1182/blood.V124.21.1910.1910

Published: 2014

Journal Articles

Wilms’ Tumor 1 Expression Levels in Bone Marrow after Induction and/or Consolidation Therapy Allow a Better Stratification of Patients and Improves Treatment in Adult AML

Blood (2014) 124 (21): 1036.

https://doi.org/10.1182/blood.V124.21.1036.1036

Published: 2014

Journal Articles

Graft Versus HIV-1 Reservoir Effect after Allogeneic Stem Cell Transplantation

Mi Kwon, MD, Monique Nijhuis, MD, Pascual Balsalobre, MSc, Jorge Gayoso, MD, Javier Anguita, MD PhD, Ismael Buno, PhD, Carolina Martinez-Laperche, PhD, David Serrano, MD, Juan Berenguer, MD, Pilar Miralles, MD, Annemarie Wensing, MD PhD, Jose Luis Diez-Martin, MD PhD

Blood (2014) 124 (21): 1234.

https://doi.org/10.1182/blood.V124.21.1234.1234

Published: 2014

Journal Articles

Differences in Natural Killer(NK) Reconstitution Between Unmanipulated Haploidentical and HLA Identical Stem Cell Transplantation and Relationship with Citomegalovirus and Graft Versus Host Disease (GVHD). Experience in One Centre in 22 Patients.

Ana María Pérez-Corral, MD, Ana Carolina Franco, Diana Champ, Jorge Gayoso, MD, Cristina Pascual, MD, Mariana Bastos-Oreiro, MD, Mi Kwon, MD, David Serrano, MD, Pascual Balsalobre, MSc, Ismael Buno, PhD, Carolina Martínez-Laperche, PhD, Elizabeth Sarmiento, Javier Anguita, MD, Jose Luis Diez-Martin, MD PhD

Blood (2014) 124 (21): 5872.

https://doi.org/10.1182/blood.V124.21.5872.5872

Published: 2014

Journal Articles

Mismatches In Killer Immunoglobulin Receptor (KIR) Ligands and Inhibitory KIR Receptors Between Donor and Recipients Improve Survival After Non T Cell Depleted Haploidentical Transplantation

Mariana Bastos-Oreiro, MD, Javier Anguita, MD, Carolina Martínez-Laperche, PhD, Almudena Navarro, Lucía Fernandez, Pascual Balsalobre, MSc, Cristina Muñoz, Mi Kwon, MD, Ana Perez, Cristina Pascual, MD, Antonio Perez, PhD, Ismael Buno, PhD, Jorge Gayoso, MD, Jose Luis Díez, MD

Blood (2013) 122 (21): 2009.

https://doi.org/10.1182/blood.V122.21.2009.2009

Published: 2013

Journal Articles

Chronic Myeloid Leukemia (CML) Patients With Atypical e1a2 P190 BCR-ABL Translocation Show a Poor Response To Therapy With Tyrosine Kinase Inhibitors (TKI)

Carme Montoriol-Sabaté, Carolina Martínez-Laperche, PhD, P Jiménez-Gámiz, Rosa Collado, PhD, Alfredo Minguela-Puras, M.A. Piñán-Francés, B. Bellosillo, Joaquín Martínez-López, MD, PhD, Marcos González, MD, María José Larrayoz, PhD, MªJose Calasanz, PhD, Maria Teresa Gomez-Casares, MD, G. González-Brito, Gloria Soler, Jose Román, A. Jimenez-Velasco, Ismael Buno, PhD

Blood (2013) 122 (21): 5193.

https://doi.org/10.1182/blood.V122.21.5193.5193

Published: 2013

Journal Articles

Donor Genotypes For Interleukin-17A Gene Single Nucleotide Polymorphisms (SNPs) Allow Anticipation Of Complications After HLA-Identical Allogeneic Stem Cell Transplantation (allo-SCT)

Blood (2013) 122 (21): 4619.

https://doi.org/10.1182/blood.V122.21.4619.4619

Published: 2013

Journal Articles

Early and Favourable Immune Reconstitution After Unmanipulated Haploidentical Stem Cell Transplantation With High Dose Post-Transplant Cyclophosphamide Regardless Intensity Of Conditioning Regimen

Isabel Gonzalez-Gascon y Marin, MD, Ana María Pérez-Corral, MD, Jorge Gayoso, MD, Javier Anguita, MD, Ana Carolina Franco, Cristina Pascual, MD, Mi Kwon, MD, David Serrano, MD, Pascual Balsalobre, MSc, Ismael Buno, PhD, Carolina Martínez-Laperche, PhD, Elisabeth Sarmiento, Jose Luis Diez-Martin, MD, PhD

Blood (2013) 122 (21): 4620.

https://doi.org/10.1182/blood.V122.21.4620.4620

Published: 2013

Journal Articles

Early Evaluation Of Natural Killer Cell Reconstitution Following Unmanipulated Haploidentical Transplantation Compared With HLA-Identical Sibling Transplantation

Isabel Gonzalez-Gascon y Marin, MD, Ana María Pérez-Corral, MD, Jorge Gayoso, MD, Javier Anguita, MD, Ana Carolina Franco, Cristina Pascual, MD, Mi Kwon, MD, David Serrano, MD, Pascual Balsalobre, MSc, Ismael Buno, PhD, Carolina Martinez-Laperche, PhD, Elisabeth Sarmiento, Jose Luis Diez-Martin, MD, PhD

Blood (2013) 122 (21): 5480.

https://doi.org/10.1182/blood.V122.21.5480.5480

Published: 2013

Journal Articles

The Presence Of Residual Disease After Induction and/Or Consolidation Therapy Based On Wilms’ Tumor 1 (WT1) Expression Is a Strong Prognostic Factor For Relapse and Survival In AML

Blood (2013) 122 (21): 1329.

https://doi.org/10.1182/blood.V122.21.1329.1329

Published: 2013

Journal Articles

Value of Pretransplantation Minimal Residual Disease in Acute Myeloid Leukemia and Myeloablative Hematopoietic Cell Transplantation.

Leyre Bento, MD, Mi Kwon, MD, Ismael Buno, PhD, Carolina Martinez-Laperche, PhD, Javier Anguita, MD, Ana M Pérez-Corral, MD, Cristina Pascual, MD, Pascual Balsalobre, MSc, David Serrano, MD, Jorge Gayoso, MD, Jose Luis Diez-Martin, PhD

Blood (2012) 120 (21): 2510.

https://doi.org/10.1182/blood.V120.21.2510.2510

Published: 2012

NARROW

Association of Gene Polymorphisms in Cyclophosphamide Metabolism Pathway with Complications after Haploidentical Hematopoietic Stem Cell Transplantation

Impact of Minimal Residual Disease and Chimerism Monitoring at Different Timepoints after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

ST2 As a Biomarker of Non-Relapse Mortality after HLA-Haploidentical SCT with High-Dose Post-Transplantation Cyclophosphamide

Immune Reconstitution Impact on Overall Survival after Hematopoietic Haploidentical Stem Cell Transplantation

Influence of CD34+ and CD3+ Graft Content on Gvhd Development after Haploidentical Allogeneic Transplantation with Post-Transplant Cyclophosphamide

A Novel Quantitative PCR Approach Targeting Insertion/Deletion Polymorphisms (Indel-PCR) for Chimerism Quantification: Finally High Sensitivity and Quantification Capacity Together

Donor and Recipient Genotypes for Interleukin 1 Gene Single Nucleotide Polymorphisms (SNPs) Allow Anticipation of Acute Graft Versus Host Disease after HLA-Identical Allogeneic Stem Cell Transplantation (allo-SCT)

Calreticulin Mutations in JAK2-Negative Myeloproliferative Neoplasms. Experience in Our Center

Chromosome 8 Abnormalities (8p Losses and 8q Gains) in Patients with Chronic Lymphocytic Leukemia (CLL) and Del(17p)

Myelodysplastic Syndromes with I(17)(q10) and Prognostic Implications of Mutations of TP53 and SETBP1

Wilms’ Tumor 1 Expression Levels in Bone Marrow after Induction and/or Consolidation Therapy Allow a Better Stratification of Patients and Improves Treatment in Adult AML

Graft Versus HIV-1 Reservoir Effect after Allogeneic Stem Cell Transplantation

Differences in Natural Killer(NK) Reconstitution Between Unmanipulated Haploidentical and HLA Identical Stem Cell Transplantation and Relationship with Citomegalovirus and Graft Versus Host Disease (GVHD). Experience in One Centre in 22 Patients.

Mismatches In Killer Immunoglobulin Receptor (KIR) Ligands and Inhibitory KIR Receptors Between Donor and Recipients Improve Survival After Non T Cell Depleted Haploidentical Transplantation

Chronic Myeloid Leukemia (CML) Patients With Atypical e1a2 P190 BCR-ABL Translocation Show a Poor Response To Therapy With Tyrosine Kinase Inhibitors (TKI)

Donor Genotypes For Interleukin-17A Gene Single Nucleotide Polymorphisms (SNPs) Allow Anticipation Of Complications After HLA-Identical Allogeneic Stem Cell Transplantation (allo-SCT)

Early and Favourable Immune Reconstitution After Unmanipulated Haploidentical Stem Cell Transplantation With High Dose Post-Transplant Cyclophosphamide Regardless Intensity Of Conditioning Regimen

Early Evaluation Of Natural Killer Cell Reconstitution Following Unmanipulated Haploidentical Transplantation Compared With HLA-Identical Sibling Transplantation

The Presence Of Residual Disease After Induction and/Or Consolidation Therapy Based On Wilms’ Tumor 1 (WT1) Expression Is a Strong Prognostic Factor For Relapse and Survival In AML

Value of Pretransplantation Minimal Residual Disease in Acute Myeloid Leukemia and Myeloablative Hematopoietic Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only